Portevo
US Companies
ELVNew York Stock Exchange

Elevance Health (ELV) Earnings

Elevance Health earnings dates, analyst consensus, and how the stock reacted to past earnings reports—all in one place.

Updated: October 11, 2026

Share Price
412.70 USD
+2.93%
Market Cap
$89.50 bn
Next Report
October 21, 2026
confirmed date
Earnings Beat
100%
out of 4 last quarters
Average Share Price Movement
7.03%
on the session after publication
P/E Ratio
18.27
Elevance Health's Earnings Performance vs. EstimatesThe company beat analyst forecasts in 100% of the last 4 quarters.100%above forecasts
Elevance Health's earnings beat consensus estimates in 4 of its most recent reports.

When Does Elevance Health Report Earnings?

Elevance Health's next earnings report is scheduled for October 21, 2026, according to the company's announcement.

The expected earnings per share (EPS) is 4.69 USD. Analyst forecasts range from 4.55 to 4.99 USD. The market reacts not to the absolute earnings, but to the difference between the actual result and this forecast.

Expected revenue: 49.16 B USD.

Elevance Health's Last Earnings Report: What the Numbers Showed

Elevance Health's last earnings report covers the quarter ending June 30, 2026. Revenue was $50.47 billion, and net income was $1.46 billion. Earnings per share reached $7.45 compared to analysts' estimates of $6.21, exceeding expectations by 19.99%. On the first trading day after the release, the stock price changed by -12.64%.

Revenue
$50.47 bn
for the quarter
Net income
$1.46 bn
for the quarter
EPS
7.45 USD
forecast 6.21
Surprise
+19.99%
vs. consensus
Share price after report
-12.64%
next trading day
Net margin
2.90%
net income to revenue

Insider Trades: Elevance Health

Who from the management board, supervisory board, US Congress, or government bought and sold shares of this company — based on official filings.

Insider Buys · 12 mo.
13
≈ $2.3M
Sales · 12 mo.
12
Unique individuals
12
in the last year
Last transaction
July 17, 2026
Latest transactionsForm 4, STOCK Act, OGE, MAR
Markwayne Mullin
$50K–$100KMay 18, 2026
Donald Trump
$15K–$50KApril 27, 2026
Donald Trump
$1K–$15KApril 27, 2026
Ramiro G Peru · Buy ELV
$366k July 17, 2026
Gail Boudreaux · Buy ELV
$1M July 17, 2026
Ronald W Penczek · Sale ELV
$149k June 12, 2026
Robert L Dixon · Sale ELV
$61k June 11, 2026
Ronald W Penczek · Sale ELV
$617k May 19, 2026
See insider faces on the chart in the app →

How the stock reacted to past earnings

The company beat analyst estimates in 100% of the last 4 quarters.

The average share price change on the day after earnings release is 7.03% — regardless of direction. The largest move was 12.64%. This number says more about the risk of holding a position through an earnings report than the earnings forecast itself.

Elevance Health Stock Reaction to EarningsBar chart: Elevance Health stock price change on the day after the last 4 earnings releases. Increased after 2 of them, decreased after 2. Largest movement: 12.64%.-2.50%X 25+7.45%I 26+5.54%Q26-12.64%Q26
Change in Elevance Health's stock price on the day of the earnings report. Green bar indicates an increase, red a decrease.
EPS Forecast vs. Actual — Elevance HealthBar chart comparing EPS forecasts with Elevance Health's actual results over the last 4 quarters. Results were higher than forecast in 4 of them.4.946.03Q3 253.093.33Q4 2510.8112.58Q1 266.217.45Q2 26analyst forecastCompany earnings
Elevance Health Earnings Per Share: Analyst Forecast vs. Actual, in USD.
Elevance Health quarterly results — forecast, actual, and stock performance on the day of the release. EPS values in USD.
QuarterRelease dateEPS estimateActual EPSSurpriseShare price reaction
June 30, 2026July 15, 20266.217.45+19.99%-12.64%
March 31, 2026April 22, 202610.8112.58+16.36%+5.54%
December 31, 2025January 28, 20263.093.33+7.65%+7.45%
September 30, 2025October 21, 20254.946.03+22.01%-2.50%

How much this company's stock moves after earnings

Elevance Health's stock price changes by an average of 7.03% on the first trading day after earnings releases, based on the last 4 reports, regardless of direction. This ranks 67 out of 180 companies for which we calculated this statistic.

Analyst forecasts for upcoming periods

The consensus is the average of many analysts' forecasts. The more analysts behind a number, the less likely it is to be a single error—but forecast agreement is never a guarantee of the actual result.

Elevance Health EPS Forecast (USD)
PeriodEPS estimateEPS a year agoChangeRevenue forecastAnalysts
Current quarter4.696.03-22.26%$49.16 bn19
Next quarter2.433.33-26.97%$48.17 bn19
Current year27.2330.29-10.09%$196.44 bn22
Next year29.5927.23+8.65%$200.24 bn22

Revenue and margins quarter by quarter

Margin shows how much of sales a company retains. Rising revenue with shrinking margins means growth is coming at the expense of profitability—and that's usually more interesting than sales growth alone.

Elevance Health Revenue and MarginsElevance Health quarterly revenue over the last 5 quarters; revenue is growing, with net margin overlaid.Q2 25Q3 25Q4 25Q1 26Q2 263.50%2.34%1.10%3.52%2.90%Quarterly revenueNet margin
Elevance Health quarterly revenue in USD and net margin for the same quarter.
Elevance Health Income Statement (Quarterly)
QuarterRevenueGross marginOperating marginNet margin
June 30, 2026$50.47 bn——2.90%
March 31, 2026$50.18 bn——3.52%
December 31, 2025$49.75 bn——1.10%
September 30, 2025$50.71 bn——2.34%
June 30, 2025$49.78 bn——3.50%

Elevance Health Dividend

The last ex-dividend date was September 10, 2026. The date of the next payment is not yet known — it depends on the resolution of the general meeting, and Yahoo only provides the date after it is announced.

Dividend Yield
1.72%
from the last payment
Per Share
6.88 USD
annually
Payout Ratio
30.37%
portion of profit returned to shareholders
Ex-dividend date
September 10, 2026
last known

Who Reports in the Coming Weeks

Dates from the Portevo calendar — companies in the same industry are listed first, as their earnings often move the share prices of their peers even before their own reports.

About Elevance Health

Elevance Health, Inc. is listed on the New York Stock Exchange under the ticker ELV and is headquartered in the United States. The company is in the Healthcare sector (industry: Healthcare Plans).

  • Ticker: ELV
  • Exchange: New York Stock Exchange
  • Trading Currency: USD
  • Sector: healthcare
  • Number of Analysts Providing Estimates: 21
  • 52-Week Range: 274.84 – 436.24
  • Company Website: https://www.elevancehealth.com

Frequently Asked Questions

When does Elevance Health release earnings?

The next report is scheduled for October 21, 2026.

What were Elevance Health's results last quarter?

For the quarter ended June 30, 2026: revenue 50.47 billion USD, net income 1.46 billion USD, EPS 7.45 USD. This was +19.99% above analyst forecasts.

What is Elevance Health's ticker?

ELV — on the New York Stock Exchange. You may also see ELV on quote services.

What is the EPS forecast for Elevance Health?

The analyst consensus for the upcoming quarter is $4.69 per share. Individual forecasts range from $4.55 to $4.99.

How much does Elevance Health's share price usually change after earnings?

On average, 7.03% in the session after publication, counting both directions. The largest recorded movement was 12.64%.

Does Elevance Health usually beat analyst forecasts?

In the last 4 quarters, results exceeded forecasts in 100% of cases. History does not predict the next report, but it shows how cautiously analysts approach this company.

Where can I check Elevance Health's financial results in English?

On Portevo — the earnings calendar, analyst forecasts, surprise history, and share price reactions are available for free and without an account.

Other companies in the healthcare sector

A company's earnings are most informative when compared to competitors in the same industry — this shows whether a weak quarter was a company-specific issue or a market-wide trend.

Related

Track Elevance Health on Portevo

The company page in the app includes a price chart, indicators, and industry comparisons. Add a company to your watchlist, and its report will be highlighted in the earnings calendar—along with the rest of your portfolio.

Portevo is not an investment advisor. The data and analyses are for informational and educational purposes only and do not constitute a recommendation or an offer to buy or sell financial instruments. Quotes are from external providers and may be delayed. You make investment decisions at your own risk.

Portevo App

Your entire portfolio, company earnings, and insider trades in one place

Upload your XTB report or add companies manually — Portevo will calculate your net profit after costs, show you the earnings dates for your companies, and display insider faces on charts.

  • Portfolio with Net Profit After Costs
  • Earnings Calendar for Your Companies
  • Pelosi, Trump, and CEO Trades on a Chart
  • Works in Browser and on iPhone

No credit card required. A demo portfolio is available immediately; create your own by uploading a report.

Portevo Portfolio: Value, Net Performance, and ChartCompany Earnings Calendar in the Portevo AppETF Fact Sheet with Quotes in PortevoTransaction History and Portfolio Tracking in Portevo
Portevo — free portfolio, earnings, and insider tradesOpen App